Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Implementation and User Satisfaction of a Comprehensive Telemedicine Approach for SARS-CoV-2 Self-Sampling: Monocentric, Prospective, Interventional, Open-Label, Controlled, Two-Arm Feasibility Study.
Voit F, Erber J, Egert-Schwender S, Hanselmann M, Laxy M, Kehl V, Hoffmann D, Jeske SD, Michler T, Protzer U, Kohlmayer F, Schmid RM, Spinner CD, Weidlich S. Voit F, et al. Among authors: kehl v. JMIR Form Res. 2024 Dec 11;8:e57608. doi: 10.2196/57608. JMIR Form Res. 2024. PMID: 39661941 Free PMC article. Clinical Trial.
Subarachnoid haemorrhage WFNS grade V: is maximal treatment worthwhile?
Wostrack M, Sandow N, Vajkoczy P, Schatlo B, Bijlenga P, Schaller K, Kehl V, Harmening K, Ringel F, Ryang YM, Friedrich B, Stoffel M, Meyer B. Wostrack M, et al. Among authors: kehl v. Acta Neurochir (Wien). 2013 Apr;155(4):579-86. doi: 10.1007/s00701-013-1634-z. Epub 2013 Feb 12. Acta Neurochir (Wien). 2013. PMID: 23397308
Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients.
Thalgott M, Rack B, Eiber M, Souvatzoglou M, Heck MM, Kronester C, Andergassen U, Kehl V, Krause BJ, Gschwend JE, Retz M, Nawroth R. Thalgott M, et al. Among authors: kehl v. BMC Cancer. 2015 Jun 9;15:458. doi: 10.1186/s12885-015-1478-4. BMC Cancer. 2015. PMID: 26051431 Free PMC article. Clinical Trial.
Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol.
Pigorsch SU, Wilkens JJ, Kampfer S, Kehl V, Hapfelmeier A, Schläger C, Bier H, Schwaiger M, Combs SE. Pigorsch SU, et al. Among authors: kehl v. Radiat Oncol. 2017 Mar 1;12(1):45. doi: 10.1186/s13014-017-0776-1. Radiat Oncol. 2017. PMID: 28249612 Free PMC article. Clinical Trial.
Surgical treatment and neurological outcome of infiltrating intramedullary astrocytoma WHO II-IV: a multicenter retrospective case series.
Butenschoen VM, Hubertus V, Janssen IK, Onken J, Wipplinger C, Mende KC, Eicker SO, Kehl V, Thomé C, Vajkoczy P, Schaller K, Gempt J, Meyer B, Wostrack M. Butenschoen VM, et al. Among authors: kehl v. J Neurooncol. 2021 Jan;151(2):181-191. doi: 10.1007/s11060-020-03647-w. Epub 2020 Oct 22. J Neurooncol. 2021. PMID: 33094355 Free PMC article.
76 results